2022
DOI: 10.31219/osf.io/afg6r
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Angiotensin-converting enzyme 2-based biosensing modalities and devices for coronavirus detection

Abstract: Rapid and cost-effective diagnostic tests for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have become a critical and valuable weapon for the coronavirus disease 2019 (COVID-19) pandemic response. SARS-CoV-2 invasion is primarily mediated by human angiotensin-converting enzyme 2 (hACE2). Recent developments in ACE2-based SARS-CoV-2 detection modalities accentuate the potential of this natural host-virus interaction for developing point-of-care (POC) COVID-19 diagnostic tools and devices. Althou… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 104 publications
0
1
0
Order By: Relevance
“…To the best of our knowledge, the MPXV entry receptor is still unknown; the discovery of the MPXV entry receptor and the development of MPXV sensors based on the entry receptor could be useful future developments. Novel MPXV biosensors could be developed based on photonics [ 95 ], quantum dots [ 96 ], electrochemiluminescence [ 97 ], electrochemical transduction, lab on a chip [ 30 ], CRISPR technology [ 98 , 99 ], and other approaches [ 100 , 101 , 102 , 103 ]. Introducing smart diagnostic systems based on WWE is anticipated to be a good future work to detect asymptomatic cases.…”
Section: Conclusion and Prospectsmentioning
confidence: 99%
“…To the best of our knowledge, the MPXV entry receptor is still unknown; the discovery of the MPXV entry receptor and the development of MPXV sensors based on the entry receptor could be useful future developments. Novel MPXV biosensors could be developed based on photonics [ 95 ], quantum dots [ 96 ], electrochemiluminescence [ 97 ], electrochemical transduction, lab on a chip [ 30 ], CRISPR technology [ 98 , 99 ], and other approaches [ 100 , 101 , 102 , 103 ]. Introducing smart diagnostic systems based on WWE is anticipated to be a good future work to detect asymptomatic cases.…”
Section: Conclusion and Prospectsmentioning
confidence: 99%